Phase 2 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 50 and 89 years
- People who have been diagnosed with Parkinson's disease at a mild to moderate stage (stages 1 to 3), as confirmed by a neurologist using recognised international diagnostic guidelines
- People who have had, on average, 5 or fewer bowel movements per week over the past 6 months, with 2 or fewer of those being fully complete — this will be checked during a 2-week screening period before the trial begins
- People whose stools have been consistently hard or lumpy over the past 6 months (a score of 3 or below on a standard stool consistency scale) — this will also be checked during the 2-week screening period
- People who agree to use contraception during the trial, if this applies to their situation
Who may not be able to join:
- People who have been diagnosed with functional diarrhoea or a mixed or diarrhoea-predominant form of irritable bowel syndrome, based on recognised diagnostic criteria
- People who have a known structural problem with their digestive system that causes symptoms, or who have inflammatory bowel disease
- People with significantly reduced liver or kidney function, as measured by specific blood test results (confirm with trial site)
- People who are currently pregnant or breastfeeding
- People who have been diagnosed with a specific bowel muscle coordination problem called primary dyssynergic defecation, identified through a specialised bowel pressure test (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard A. Manfready, MD, AM, FACP, Cedar Valley Digestive Health Center
Phone: (319) 235-5390
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete spontaneous bowel movements (CSBM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.